| Company Name: |
Guangzhou PI PI Biotech Inc
|
| Tel: |
020-81716320 +86-13602409664 |
| Email: |
Sales@pipitech.com |
| Products Intro: |
Product Name:rac-Ruxolitinib-13C,15N2
Purity:90%+ Package:10mg, 25mg, 50mg, 100mg, Other scale please email Sales@pipitech.com Remarks:β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile
|
| Company Name: |
Chemsky (shanghai) International Co.,Ltd
|
| Tel: |
021-50135380 |
| Email: |
shchemsky@sina.com |
| Products Intro: |
Product Name:rac-Ruxolitinib-d8;β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile; INCB 018424-d8
Purity:98+% Package:1Mg;5Mg;10Mg;50Mg;100Mg;500Mg
|
| Company Name: |
Hubei Yangxin Medical Technology Co., Ltd.
|
| Tel: |
15374522761 |
| Email: |
3003392093@qq.com |
| Products Intro: |
Product Name:Ruxolitinib Impurity 7-d8
CAS:1794791-38-0
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
PI & PI BIOTECH INC.
|
| Tel: |
020-81716320 17788709170 |
| Email: |
Sales@pipitech.com |
| Products Intro: |
|
| Company Name: |
Nanjing Shizhou Biology Technology Co.,Ltd
|
| Tel: |
17301488900 |
| Email: |
judy.xia@synzest.com |
| Products Intro: |
Product Name:rac-Ruxolitinib-d9 (major)
CAS:1794791-38-0
Purity:98% Package:1mg;5mg;10mg;100mg
|
|
| | INCB 018424-13C,15N2 Basic information |
| Product Name: | INCB 018424-13C,15N2 | | Synonyms: | INCB 018424-13C,15N2;rac-Ruxolitinib-13C,15N2;β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile;INCB 018424-d8;rac-Ruxolitinib-d8 | | CAS: | 1794791-38-0 | | MF: | C17H18N6 | | MW: | 306.37 | | EINECS: | | | Product Categories: | | | Mol File: | 1794791-38-0.mol |  |
| | INCB 018424-13C,15N2 Chemical Properties |
| form | Solid | | color | White to off-white |
| | INCB 018424-13C,15N2 Usage And Synthesis |
| Uses | Labelled racemic analogue of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. | | Uses | As labelled racemic analogue of Ruxolitinib (R702000), rac-Ruxolitinib-13C,15N2 is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis. |
| | INCB 018424-13C,15N2 Preparation Products And Raw materials |
|